Ricolinostat is not a highly selective HDAC6 inhibitor

被引：7

作者：

Medard, Guillaume ^{[1
]}

Sheltzer, Jason M. ^{[2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Dept Chem, Prote Core Facil, Athens, Greece

[2] Yale Univ, Sch Med, New Haven, CT 06520 USA

来源：

NATURE CANCER | 2023年 / 4卷 / 06期

关键词：

D O I：

10.1038/s43018-023-00582-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：807 / 808

页数：2

共 12 条

[1] Broad Institute, 2021, HDAC6 DEPMAP GEN SUM
[2] Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
Depetter, Yves
Geurs, Silke
De Vreese, Rob
Goethals, Sophie
Vandoorn, Elien
Laevens, Alien
Steenbrugge, Jonas
Meyer, Evelyne
de Tullio, Pascal
Bracke, Marc
D'hooghe, Matthias
De Wever, Olivier
[J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (03) : 735 - 747
[3] Chemoproteomics-Aided Medicinal Chemistry for the Discovery of EPHA2 Inhibitors
Heinzlmeir, Stephanie
Lohse, Jonas
Treiber, Tobias
Kudlinzki, Denis
Linhard, Verena
Gande, Santosh Lakshmi
Sreeramulu, Sridhar
Saxena, Krishna
Liu, Xiaofeng
Wilhelm, Mathias
Schwalbe, Harald
Kuster, Bernhard
Medard, Guillaume
[J]. CHEMMEDCHEM, 2017, 12 (12) : 999 - 1011
[4] Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target
Lechner, Severin
Malgapo, Martin Ian P.
Graetz, Christian
Steimbach, Raphael R.
Baron, Agnes
Ruether, Patrick
Nadal, Simon
Stumpf, Carmen
Loos, Christina
Ku, Xin
Prokofeva, Polina
Lautenbacher, Ludwig
Heimburg, Tino
Wuerf, Vivian
Meng, Chen
Wilhelm, Mathias
Sippl, Wolfgang
Kleigrewe, Karin
Pauling, Josch K.
Kramer, Karl
Miller, Aubry K.
Pfaffl, Michael W.
Linder, Maurine E.
Kuster, Bernhard
Medard, Guillaume
[J]. NATURE CHEMICAL BIOLOGY, 2022, 18 (08) : 812 - +
[5] Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Lin, Ann
Giuliano, Christopher J.
Palladino, Ann
John, Kristen M.
Abramowicz, Connor
Yuan, Monet Lou
Sausville, Erin L.
Lukow, Devon A.
Liu, Luwei
Chait, Alexander R.
Galluzzo, Zachary C.
Tucker, Clara
Sheltzer, Jason M.
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (509)
[6] Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Meyers, Robin M.
Bryan, Jordan G.
McFarland, James M.
Weir, Barbara A.
Sizemore, Ann E.
Xu, Han
Dharia, Neekesh V.
Montgomery, Phillip G.
Cowley, Glenn S.
Pantel, Sasha
Goodale, Amy
Lee, Yenarae
Ali, Levi D.
Jiang, Guozhi
Lubonja, Rakela
Harrington, William F.
Strickland, Matthew
Wu, Ting
Hawes, Derek C.
Zhivich, Victor A.
Wyatt, Meghan R.
Kalani, Zohra
Chang, Jaime J.
Okamoto, Michael
Stegmaier, Kimberly
Golub, Todd R.
Boehm, Jesse S.
Vazquez, Francisca
Root, David E.
Hahn, William C.
Tsherniak, Aviad
[J]. NATURE GENETICS, 2017, 49 (12) : 1779 - +
[7] A comparative safety review of histone deacetylase inhibitors for the treatment of myeloma
Seval, Guldane Cengiz
Beksac, Meral
[J]. EXPERT OPINION ON DRUG SAFETY, 2019, 18 (07) : 563 - 571
[8] Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
Shah, Rashmi R.
[J]. DRUG SAFETY, 2019, 42 (02) : 235 - 245
[9] Reply to: Ricolinostat is not a highly selective HDAC6 inhibitor
Silva, Jose
Yu, Jiyang
Kalinsky, Kevin
[J]. NATURE CANCER, 2023, 4 (06) : 809 - 811
[10] Defining a Cancer Dependency Map
Tsherniak, Aviad
Vazquez, Francisca
Montgomery, Phil G.
Weir, Barbara A.
Kryukov, Gregory
Cowley, Glenn S.
Gill, Stanley
Harrington, William F.
Pantel, Sasha
Krill-Burger, John M.
Meyers, Robin M.
Ali, Levi
Goodale, Amy
Lee, Yenarae
Jiang, Guozhi
Hsiao, Jessica
Gerath, William F. J.
Howell, Sara
Merkel, Erin
Ghandi, Mahmoud
Garraway, Levi A.
Root, David E.
Golub, Todd R.
Boehm, Jesse S.
Hahn, William C.
[J]. CELL, 2017, 170 (03) : 564 - +

← 1 2 →